F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review the facility failed to implement the comprehensive care plan
related to hearing for one resident (#15) of one resident sampled for hearing.
Findings included:
An interview was attempted with Resident #15 on 02/28/2022 at 10:42 a.m. Resident #15 was making the
bed and when asked questions she continually stated she did not understand due to hearing issues. The
resident stated she did not have hearing aids.
A review of Resident #15's admission Record revealed an admission date of 01/10/2020 with medical
diagnoses of unspecified dementia, and major depressive disorder.
A review of Resident #15's care plan, initiated on 1/13/2020, revealed a communication deficit related to
hearing loss and deafness in the right ear. This focus area had a target date of 03/30/2022. Interventions for
this deficit included ensuring availability of adaptive communication equipment and ensuring a left hearing
aid was in place.
A review of Resident #15's Quarterly Minimum Data Set (MDS), dated [DATE], revealed in Section C Cognitive Patterns the resident had a Brief Interview for Mental Status score of 14. A score of 14 indicated
the resident had intact cognition without signs of disorganized thinking. Further review of the MDS revealed
in Section B - Hearing, Speech, and Vision the resident used a hearing aid.
An interview with Resident #15's Responsible Party confirmed the resident was hard of hearing and never
had hearing aids . she never got them.
Interviews conducted with Staff A, Certified Nursing Assistant on 03/01/2022 at 10:40 a.m., and Staff B,
Registered Nurse on 03/01/2022 at 10:55 a.m. confirmed the resident was extremely hard of hearing,
however, neither direct staff member were aware of any hearing aids belonging to Resident #15.
An interview on 03/01/2022 at 11:01 a.m. with the Social Services Director (SSD) revealed Resident #15
never had hearing aids and confirmed both the resident's care plan and MDS indicated the resident had
hearing aids. The SSD was unsure how the care plan was created and the MDS indicating the resident had
hearing aids when she never did.
On 03/01/2022 at 11:27 a.m. the Director of Nursing (DON) stated the MDS and the care plan had incorrect
information. The DON stated she contacted the Responsible Party who did not think Resident #15
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
105959
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105959
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/02/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Addington Place at College Harbor
4600 54th Ave S
Saint Petersburg, FL 33711
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
would benefit from hearing aids due to her age and memory. However, the resident can voice her wants
and when asked, the resident stated she was willing to participate in a hearing assessment to verify if she
would benefit from hearing aids. Resident #15 was added to the hearing evaluation list.
A policy review of Hearing and Vision Services, implemented on 10/15/2021, revealed, It is the policy of this
facility to ensure that residents receive proper treatment and assistive devices to maintain vision and
hearing abilities. The facility, if necessary will assist the resident in making appointments and arranging
transportation to and from the office of a practitioner . Assistive devices to maintain hearing include hearing
aides and amplifiers.
A policy review of Comprehensive Care Plans, revised on 10/15/2021, revealed, It is the policy of this
facility to develop and implement a comprehensive person-centered care plan for each resident, consistent
with resident rights, that includes measurable objectives and timeframes to meet a residence medical,
nursing, and mental and psychosocial meats that are identified in the resident's comprehensive
assessment .
1. The care planning process will include an assessment of the resident's strengths and needs, and will
incorporate the resident's personal and cultural preferences in developing goals of care. Services provided
or arranged by the facility, as outlined by the comprehensive care plan, shall be culturally competent and
trauma informed .
3. A comprehensive care plan will describe, at a minimum, the following:
a. The services that are to be furnished to attain or maintain the residence highest practical physical,
mental, and psychosocial well-being.
b. Any services that would otherwise be furnished, but are not provided due to the residents exercising her
right to refuse treatment
5. The comprehensive care plan will include measurable objectives and timeframes to meet the residents
needs as identified in the residence comprehensive assessment. The objectives will be utilized to monitor
the resident's progress. Alternative interventions will be documented, as needed.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105959
If continuation sheet
Page 2 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105959
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/02/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Addington Place at College Harbor
4600 54th Ave S
Saint Petersburg, FL 33711
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview and record review, the facility did not ensure the medication error rate was
less than 5.00%. A total of twenty-six medications were observed administered, and four errors were
identified for three residents (#14, #25 and #28) of six residents observed. These errors constituted a
medication error rate of 15.38%.
Residents Affected - Few
Findings included:
On 02/28/2022 at 10:11 a.m., an observation of medication administration with
Staff C, Registered Nurse (RN) was conducted with Resident #25. Staff C, RN was observed administering
the following medications:
Trelegy Ellipta Aerosol Powder Breath Activated 200-62.5-25 MCG/INH (microgram/inhaled) 1 puff inhale
orally one time day,
Aspirin Tablet Give 81MG (milligram) orally,
Multivitamin Adult Tablet orally,
Sertraline HCL Tablet 150 MG orally.
A review of the March 2022 Medication Administration Record (MAR) for Resident #25 revealed the
Trelegy Ellipta Aerosol Powder Breath Activated 200-62.5-25 MCG/INH 1 puff inhale orally one time day for
Diagnosis of Wheezing is to be administered to the resident in the morning with instructions to rinse his
mouth with water and spit out afterwards.
An immediate interview with Staff C, RN was conducted and she confirmed she administered the Trelegy
Ellipta Aerosol medication first, then the other medications, and Resident #25 did not rinse his mouth after
the aerosol medication was administered.
A review of facility policy titled, Specific Medication Administration Procedures, Dated April 2018, Page 125,
under Metered Dose and Dry Powder Inhalers revealed:
Q. For steroid inhalers, provide resident with cup of water and instruct him/her to rinse mouth and spit water
back into cup.
On 02/28/2022 at 10:40 a.m., an observation of medication administration with Staff C, RN was conducted
with Resident #14. Staff C, RN was observed administering the following medications:
Aspirin Tablet Chewable 81MG orally,
Amiodarone HCL Tablet 100MG orally,
Senna Docusate Sodium Tablet 8.6-50MG,
Cholecalciferol tablet 50 MCG orally,
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105959
If continuation sheet
Page 3 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105959
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/02/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Addington Place at College Harbor
4600 54th Ave S
Saint Petersburg, FL 33711
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Tramadol HCL Tablet 50 MG orally,
Level of Harm - Minimal harm
or potential for actual harm
Lidoderm Patch (Lidocaine) Applied to each knee,
Chocolate Boost (237ml [milliliters]).
Residents Affected - Few
A review of the March 2022 MAR for Resident #14 revealed the above medications were scheduled to be
administered at 9:00 a.m., and the resident had a Physician Order to take Med pass nutritional vitamin
supplement for 14 days/120 ML orally three times a day.
An immediate interview was conducted with Staff C, RN, who confirmed the above medications were
scheduled to be administered at 9:00 a.m. Staff C also revealed she did not have Med Pass 2.0 and had to
substitute it for Boost during medication administration. She was asked if the facility and physician or
dietician was aware of the substitution and she stated, I have to tell them.
On 02/28/2022 at 11:05 a.m. an observation was conducted on Staff D's, Licensed Practical Nurse(LPN)
medication cart, which had Med Pass 2.0 on it, in a container on ice. Staff D, LPN confirmed the Med Pass
2.0 on the cart and revealed it is located in the supply room.
On 02/28/2022 at 11:00 a.m., an observation of medication administration for Resident #28 was conducted
with Staff D, LPN. Staff D, LPN was observed administering the following medication:
Novolog Pen Fill Solution Cartridge 100Unit/ML (Insulin Aspart) of five units for Blood sugar of 215, on a
sliding scale of 201-250=5 units. Staff D, LPN was seen to dial five units into the flex pen and administer the
insulin in Resident #28's left upper arm. Staff D, LPN did not prime the pen prior to administering the
medication.
An immediate interview was conducted with Staff D, LPN after administration of the insulin, related to not
priming the pen and she stated, I didn't realize that that was something that needed to be done before you
use it.
A review of the March 2022 MAR for Resident #28 revealed Novolog Pen Fill Solution Cartridge 100Unit/ML
(Insulin Aspart) inject per sliding scale of 201-250=5 units.
Review of (Vendor Name) Pharmacy Policy titled, Insulin Pen Administration, with Manufacturer Instructions
from Novo Nordisk revealed:
Priming Your Pen-Must Prime before each injection!
Step 5: Priming the pen means removing air from the Needle and Cartridge that may collect during normal
use and ensures that the pen is working correctly.
-If you do not prime before each injection, you may get too much or too little insulin.
Step 6: To prime your pen, turn the Dose Knob to select 2 units.
Step 7: Hold your pen with the Needle pointing up. Tap the Cartridge Holder gently to collect air bubbles art
the top.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105959
If continuation sheet
Page 4 of 5
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105959
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/02/2022
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Addington Place at College Harbor
4600 54th Ave S
Saint Petersburg, FL 33711
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Step 8: Continue holding your Pen with Needle pointing up. Push the Dose Knob in until it stops, and 0 is
seen in the Dose Window. Hold the Dose Knob in and count to 5 slowly.
An interview with the Director of Nursing (DON) was conducted on 02/28/2022 at 11:50 a.m., and she
indicated it was her expectation that nursing staff prime Flex Pens per facility policy prior to the
administration of insulin. She further revealed medications should not be given late at any time, and she
was going to call the physician herself to inform him, and see if he wanted to give new orders considering
they were late. The DON further indicated it is not standard practice for a nurse not to follow physician
orders, and substitute a supplement for another supplement, and she was unaware that Staff C, RN did
this. She stated, The facility has Med Pass 2.0 in stock. The DON asked the Nursing Home Administrator
(NHA) at this time to replace it on Staff C's, medication cart. The DON stated, This is a medication error.
On 03/01/2022 at 11:18 a.m., a telephone interview was conducted with the Pharmacy Consultant. The
Pharmacy Consultant was informed of the observations made of Staff C, RN and Staff D, LPN, and
revealed it is standard nursing practice to prime the pen first, prior to administering insulin to a resident. He
further indicated that nursing staff must follow physician orders and it is his expectation if the order is for
Med Pass 2.0 it is given, and not substituted by the nurse for another item (Boost). The Pharmacy
Consultant said all corticosteroid inhalers have instructions for the resident to rinse and spit out afterwards
and nursing staff should follow the pharmacy label directions placed on each medication prior to and during
medication administration.
During a subsequent interview with the Pharmacy Consultant, on 03/02/2022 at 9:25 a.m., he indicated his
expectation was 9:00 a.m. medications are given on time and that 10:40 a.m. is a late administration and
not within the scope of facility policy.
A review of a facility policy titled, Preparation and General Guidelines, dated April 2018, revealed:
B. Administration
2. Medications are administered in accordance with written orders of the prescriber.
12. Medications are administered within (60 minutes) of scheduled times. Unless otherwise specified by the
prescriber, routine medications are administered according to established medication administration
schedule for the facility.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105959
If continuation sheet
Page 5 of 5